- Formation of DNA Adducts by Ellipticine and Its Micellar Form in Rats - A Comparative Study2014 | Faculty of Science
- Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitro2015 | Faculty of Science, Second Faculty of Medicine
- The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells2009 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- The effect of benzo[a]pyrene on metabolic activation of anticancer drug ellipticine in mice2013 | Faculty of Science
- The Anticancer Drug Ellipticine Induces Cytochromes P450 1A1, 1A2 and 3A, Cytochrome b(5) and NADPH:Cytochrome P450 Oxidoreductase in Rat Liver, Kidney and Lung2013 | Faculty of Science
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Second Faculty of Medicine
- The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells2018 | Faculty of Science, Second Faculty of Medicine
- Ellipticine cytotoxicity to cancer cell lines - a comparative study2011 | Second Faculty of Medicine
- Ellipticine cytotoxicity to cancer cell lines - a comparative study2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- Electrochemical Determination of Enzymes Metabolizing Ellipticine in Thyroid Cancer Cells - a Tool to Explain the Mechanism of Ellipticine Toxicity to these Cells2013 | Faculty of Science, Second Faculty of Medicine
- Electrochemical Determination of Enzymes Metabolizing Ellipticine in Thyroid Cancer Cells - a Tool to Explain the Mechanism of Ellipticine Toxicity to these Cells2013 | Publication without faculty affiliation
- Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells2015 | Faculty of Science, Second Faculty of Medicine
- Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells2019 | Faculty of Science, Second Faculty of Medicine
- Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the P-32-postlabeling technique2012 | Faculty of Science, Second Faculty of Medicine
- The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN (TM)) Mice and Pure Enzymes2015 | Faculty of Science
- Effectiveness of human cytochrome P450 3A4 present in liposomal and microsomal nanoparticles in formation of covalent DNA adducts by ellipticine2016 | Faculty of Science, Second Faculty of Medicine
- The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells2009 | Second Faculty of Medicine
- Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the P-32-postlabeling technique2012 | Second Faculty of Medicine
- Cytochrome b(5) plays a dual role in the reaction cycle of cytochrome P450 3A4 during oxidation of the anticancer drug ellipticine2017 | Faculty of Science, Second Faculty of Medicine